Characteristics of patients with late recurrence endometrial cancer
Rattachement africain : tr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
AIM: We planned this study to assess endometrial cancer (EC) patients who had late metastasis. MATERIALS AND METHODS: This retrospective study constituted a review of the records of patients who were diagnosed with EC and underwent hysterectomy at the Gynecologic Oncology Clinic between 1996 and 2018. Relapses occurring after the first three years following primary treatment of EC are considered late recurrences. Post-relapse survival (PRS) refers to the time to the last follow-up or the patient's death after relapse. RESULTS: Late metastases were identified in 42 patients, 20 (47.6%) of whom had locoregional recurrence and 22 of whom (52.4%) had extrapelvic recurrence. Median disease-free survival (DFS) times were 61 (range: 43-78) and 65 (range: 48-81) months for the groups with locoregional and extrapelvic recurrences, respectively (P = 0.462). The 5-year PRS rate for the patients was 61.1%, with 63.8% having locoregional and 59.4% having extrapelvic late metastasis (P = 0.969). CONCLUSION: Among the patients with late metastases, those with endometrioid type EC were found to have a better prognosis. It has been shown that locoregional or extrapelvic organ recurrence does not significantly affect survival in patients with late relapse. Although our results are not statistically significant for cases of locoregional late metastases, surgical resection increases survival rates.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Characteristics of patients with late recurrence endometrial cancer
- Date Crossref
- 08/04/2023
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Izmir Tepecik Eğitim ve Araştırma Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Erciyes University pays non établi dans la noticeUniversité ou école supérieure
-
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Muğla University pays non établi dans la noticeUniversité ou école supérieure
-
Tepecik Education and Research Hospital Department of Obstetrics and Gynecology pays non établi dans la noticeÉtablissement de santé
-
Faculty of Medicine Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Sadi Konuk Education and Research Hospital Department of Obstetrics and Gynecology pays non établi dans la noticeÉtablissement de santé
Izmir Tepecik Eğitim ve Araştırma Hastanesi, Erciyes University et Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi, avec 4 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.